| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Renal Section, Division of Medicine and
British Heart Foundation Cardiovascular Medicine Unit, National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom; and
Biogen, Inc., Cambridge, MA 02142
The migration of leukocytes into glomeruli in crescentic glomerulonephritis is fundamental to pathogenesis, and offers important therapeutic opportunities. We addressed the importance of VCAM-1, and its leukocyte ligand very late antigen-4 (VLA-4), in such leukocyte migration. In a rat model of nephrotoxic nephritis, glomerular expression of VCAM-1, studied by immunohistochemistry, was up-regulated by day 6 of nephritis. To quantify kidney endothelial VCAM-1 expression, a differential radiolabeled mAb technique was used, which demonstrated that protein expression was not up-regulated by day 2 of nephritis, but rose threefold between days 2 and 5, and remained elevated until at least day 28. An in vivo study was then performed, using blocking mAbs to either VCAM-1 or VLA-4, starting mAb treatment on the day prior to disease induction, and continuing until animals were sacrificed at day 7. mAbs to VLA-4 significantly attenuated renal injury (albuminuria, glomerular fibrinoid necrosis, and crescent formation), but mAbs to VCAM-1 had no significant effect. Surprisingly, the number of leukocytes within glomeruli was unaffected by anti-VLA-4 mAb therapy, despite the reduction in renal injury. Paradoxically, classical markers of macrophage activation were increased in the anti-VLA-4- and anti-VCAM-1-treated animals. This study demonstrates that kidney endothelial VCAM-1, in contrast to ICAM-1, is not up-regulated by day 2 of nephrotoxic nephritis, and plays little part in early leukocyte influx into glomeruli. However, VLA-4 is an important mediator of glomerular injury, operating after transendothelial leukocyte migration, and presumably binding to alternate ligands within the kidney.
This article has been cited by other articles:
|
|
 |
|
  S. A. Asgeirsdottir, J. A. A. M. Kamps, H. I. Bakker, P. J. Zwiers, P. Heeringa, K. van der Weide, H. van Goor, A. H. Petersen, H. Morselt, H. E. Moorlag, et al. Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium Mol. Pharmacol., July 1, 2007; 72(1): 121 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Timoshanko, A. R. Kitching, T. J. Semple, S. R. Holdsworth, and P. G. Tipping Granulocyte Macrophage Colony-Stimulating Factor Expression by Both Renal Parenchymal and Immune Cells Mediates Murine Crescentic Glomerulonephritis J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2646 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikezumi, L. Hurst, R. C. Atkins, and D. J. Nikolic-Paterson Macrophage-Mediated Renal Injury Is Dependent on Signaling via the JNK Pathway J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1775 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Bellingan, P. Xu, H. Cooksley, H. Cauldwell, A. Shock, S. Bottoms, C. Haslett, S. E. Mutsaers, and G. J. Laurent Adhesion Molecule-dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal Inflammation J. Exp. Med., December 2, 2002; 196(11): 1515 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. T. Cook, S. B. Khan, A. Allen, G. Bhangal, J. Smith, R. R. Lobb, and C. D. Pusey Treatment with an Antibody to VLA-1 Integrin Reduces Glomerular and Tubulointerstitial Scarring in a Rat Model of Crescentic Glomerulonephritis Am. J. Pathol., October 1, 2002; 161(4): 1265 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Kluth, C. V. Ainslie, W. P. Pearce, S. Finlay, D. Clarke, I. Anegon, and A. J. Rees Macrophages Transfected with Adenovirus to Express IL-4 Reduce Inflammation in Experimental Glomerulonephritis J. Immunol., April 1, 2001; 166(7): 4728 - 4736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Karkar, J. Smith, and C. D. Pusey Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-{{alpha}} Nephrol. Dial. Transplant., March 1, 2001; 16(3): 518 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Larbi, A. R. Allen, F. W. K. Tam, D. O. Haskard, R. R. Lobb, P. M. R. Silva, and S. Nourshargh VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration Blood, November 15, 2000; 96(10): 3601 - 3609. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
